379 related articles for article (PubMed ID: 16954334)
21. The AMP-activated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle.
Lemieux K; Konrad D; Klip A; Marette A
FASEB J; 2003 Sep; 17(12):1658-65. PubMed ID: 12958172
[TBL] [Abstract][Full Text] [Related]
22. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.
Bonen A; Han XX; Habets DD; Febbraio M; Glatz JF; Luiken JJ
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1740-9. PubMed ID: 17264223
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle.
Lira VA; Soltow QA; Long JH; Betters JL; Sellman JE; Criswell DS
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1062-8. PubMed ID: 17666490
[TBL] [Abstract][Full Text] [Related]
24. Alpha2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise.
Miura S; Kai Y; Kamei Y; Bruce CR; Kubota N; Febbraio MA; Kadowaki T; Ezaki O
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E47-55. PubMed ID: 18940938
[TBL] [Abstract][Full Text] [Related]
25. Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle.
Ai H; Ihlemann J; Hellsten Y; Lauritzen HP; Hardie DG; Galbo H; Ploug T
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1291-300. PubMed ID: 12006359
[TBL] [Abstract][Full Text] [Related]
26. Reductions in RIP140 are not required for exercise- and AICAR-mediated increases in skeletal muscle mitochondrial content.
Frier BC; Hancock CR; Little JP; Fillmore N; Bliss TA; Thomson DM; Wan Z; Wright DC
J Appl Physiol (1985); 2011 Sep; 111(3):688-95. PubMed ID: 21700896
[TBL] [Abstract][Full Text] [Related]
27. Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation.
Jørgensen SB; Honeyman J; Oakhill JS; Fazakerley D; Stöckli J; Kemp BE; Steinberg GR
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E57-66. PubMed ID: 19435854
[TBL] [Abstract][Full Text] [Related]
28. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
[TBL] [Abstract][Full Text] [Related]
29. AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle.
Stoppani J; Hildebrandt AL; Sakamoto K; Cameron-Smith D; Goodyear LJ; Neufer PD
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1239-48. PubMed ID: 12388122
[TBL] [Abstract][Full Text] [Related]
30. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
[TBL] [Abstract][Full Text] [Related]
31. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: potential role of AMP-activated protein kinase.
Kristiansen SB; Solskov L; Jessen N; Løfgren B; Schmitz O; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Lund S
Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):10-6. PubMed ID: 19486332
[TBL] [Abstract][Full Text] [Related]
32. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits.
Treebak JT; Glund S; Deshmukh A; Klein DK; Long YC; Jensen TE; Jørgensen SB; Viollet B; Andersson L; Neumann D; Wallimann T; Richter EA; Chibalin AV; Zierath JR; Wojtaszewski JF
Diabetes; 2006 Jul; 55(7):2051-8. PubMed ID: 16804075
[TBL] [Abstract][Full Text] [Related]
33. The effect of AMP-activated kinase activation on gonadotrophin-releasing hormone secretion in GT1-7 cells and its potential role in hypothalamic regulation of the oestrous cyclicity in rats.
Coyral-Castel S; Tosca L; Ferreira G; Jeanpierre E; Rame C; Lomet D; Caraty A; Monget P; Chabrolle C; Dupont J
J Neuroendocrinol; 2008 Mar; 20(3):335-46. PubMed ID: 18194429
[TBL] [Abstract][Full Text] [Related]
34. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles.
Jessen N; Pold R; Buhl ES; Jensen LS; Schmitz O; Lund S
J Appl Physiol (1985); 2003 Apr; 94(4):1373-9. PubMed ID: 12496137
[TBL] [Abstract][Full Text] [Related]
35. Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca(2+).
Ojuka EO; Jones TE; Nolte LA; Chen M; Wamhoff BR; Sturek M; Holloszy JO
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1008-13. PubMed ID: 11934664
[TBL] [Abstract][Full Text] [Related]
36. Effect of exercise intensity and AICAR on isoform-specific expressions of murine skeletal muscle PGC-1α mRNA: a role of β₂-adrenergic receptor activation.
Tadaishi M; Miura S; Kai Y; Kawasaki E; Koshinaka K; Kawanaka K; Nagata J; Oishi Y; Ezaki O
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E341-9. PubMed ID: 21098736
[TBL] [Abstract][Full Text] [Related]
37. Differential attenuation of AMPK activation during acute exercise following exercise training or AICAR treatment.
McConell GK; Manimmanakorn A; Lee-Young RS; Kemp BE; Linden KC; Wadley GD
J Appl Physiol (1985); 2008 Nov; 105(5):1422-7. PubMed ID: 18703760
[TBL] [Abstract][Full Text] [Related]
38. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y
Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850
[TBL] [Abstract][Full Text] [Related]
39. PGC-1alpha is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle.
Leick L; Wojtaszewski JF; Johansen ST; Kiilerich K; Comes G; Hellsten Y; Hidalgo J; Pilegaard H
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E463-74. PubMed ID: 18073319
[TBL] [Abstract][Full Text] [Related]
40. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
